See also this year's filing and all EDGAR filings for this company.
PDF Report 0001618835_2020_Evofem_Biosciences_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.0014116816657843657, 'aggregate_val': 28295000, 'exp_sum': 28335000, 'exp_to_value': {'AssetsCurrent': 26421000, 'IntangibleAssetsNetIncludingGoodwill': 0, 'PropertyPlantAndEquipmentNet': 394000, 'remainder_Assets': 1520000}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001618835')"} |
Graph
Absolute values for 0001618835, Evofem Biosciences Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 26,421,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 394,000 |
| 3 | remainder_Assets | 1,480,000 |
| 4 | LiabilitiesCurrent | 12,659,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 30,512,000 |
| 9 | ResearchAndDevelopmentExpense | 22,230,000 |
| 10 | remainder_Expenses | 4,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -27,287,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 28,295,000 |
| 1 | Liabilities | 12,659,000 |
| 2 | Expenses | 52,746,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 15,636,000 |
| 5 | NetIncome | -80,033,000 |
| 6 | ComprehensiveNetIncome | -80,033,000 |
| 7 | BaseVar | 60,493,500 |
| 8 | EconomicCapitalRatio | -2.60 |
Edgar->Model Mapping
Feature Distribution
Change over Time
